Moolec Science SA (MLEC) Stock Forecast, Price Target & Predictions
MLEC Stock Forecast
Moolec Science SA stock forecast is as follows: an average price target of $3.00 (represents a 294.58% upside from MLEC’s last price of $0.76) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
MLEC Price Target
The average price target for Moolec Science SA (MLEC) is $3.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $3.00. This represents a potential 294.58% upside from MLEC's last price of $0.76.
MLEC Analyst Ratings
According to 1 Wall Street analysts, Moolec Science SA's rating consensus is 'Buy'. The analyst rating breakdown for MLEC stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Moolec Science SA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 03, 2024 | Anthony Vendetti | Maxim Group | $3.00 | $0.85 | 252.94% | 294.58% |
The latest Moolec Science SA stock forecast, released on Oct 03, 2024 by Anthony Vendetti from Maxim Group, set a price target of $3.00, which represents a 252.94% increase from the stock price at the time of the forecast ($0.85), and a 294.58% increase from MLEC last price ($0.76).
Moolec Science SA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $3.00 | $3.00 |
| Last Closing Price | $0.76 | $0.76 | $0.76 |
| Upside/Downside | -100.00% | 294.58% | 294.58% |
In the current month, the average price target of Moolec Science SA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Moolec Science SA's last price of $0.76. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 03, 2024 | Maxim Group | Buy | Buy | Hold |
Moolec Science SA's last stock rating was published by Maxim Group on Oct 03, 2024. The company gave MLEC a "Buy" rating, the same as its previous rate.
Moolec Science SA Financial Forecast
Moolec Science SA Revenue Forecast
| Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Avg Forecast | $2.01M | $2.01M | $1.31M | $1.31M | $1.25M | $650.00K | $600.00K | $630.00K |
| High Forecast | $2.01M | $2.01M | $1.31M | $1.31M | $1.25M | $650.00K | $600.00K | $630.00K |
| Low Forecast | $2.01M | $2.01M | $1.31M | $1.31M | $1.25M | $650.00K | $600.00K | $630.00K |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - |
Moolec Science SA's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. MLEC's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Moolec Science SA EBITDA Forecast
| Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - |
| Avg Forecast | $670.00K | $669.00K | $438.33K | $436.33K | $418.33K | $216.67K | $200.00K | $210.00K |
| High Forecast | $670.00K | $669.00K | $438.33K | $436.33K | $418.33K | $216.67K | $200.00K | $210.00K |
| Low Forecast | $670.00K | $669.00K | $438.33K | $436.33K | $418.33K | $216.67K | $200.00K | $210.00K |
| Surprise % | - | - | - | - | - | - | - | - |
undefined analysts predict MLEC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Moolec Science SA's previous annual EBITDA (undefined) of $NaN.
Moolec Science SA Net Income Forecast
| Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - |
| Avg Forecast | $-2.64M | $-2.27M | $-2.27M | $-2.64M | $-2.27M | $-2.64M | $-2.64M | $-1.89M |
| High Forecast | $-2.64M | $-2.27M | $-2.27M | $-2.64M | $-2.27M | $-2.64M | $-2.64M | $-1.89M |
| Low Forecast | $-2.64M | $-2.27M | $-2.27M | $-2.64M | $-2.27M | $-2.64M | $-2.64M | $-1.89M |
| Surprise % | - | - | - | - | - | - | - | - |
Moolec Science SA's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. MLEC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Moolec Science SA SG&A Forecast
| Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - |
| Avg Forecast | $36.63M | $36.58M | $23.97M | $23.86M | $22.87M | $11.85M | $10.93M | $11.48M |
| High Forecast | $36.63M | $36.58M | $23.97M | $23.86M | $22.87M | $11.85M | $10.93M | $11.48M |
| Low Forecast | $36.63M | $36.58M | $23.97M | $23.86M | $22.87M | $11.85M | $10.93M | $11.48M |
| Surprise % | - | - | - | - | - | - | - | - |
Moolec Science SA's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to MLEC last annual SG&A of $NaN (undefined).
Moolec Science SA EPS Forecast
| Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - |
| Avg Forecast | $-0.07 | $-0.06 | $-0.06 | $-0.07 | $-0.06 | $-0.07 | $-0.07 | $-0.05 |
| High Forecast | $-0.07 | $-0.06 | $-0.06 | $-0.07 | $-0.06 | $-0.07 | $-0.07 | $-0.05 |
| Low Forecast | $-0.07 | $-0.06 | $-0.06 | $-0.07 | $-0.06 | $-0.07 | $-0.07 | $-0.05 |
| Surprise % | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Moolec Science SA's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to MLEC previous annual EPS of $NaN (undefined).
Moolec Science SA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| STTK | Shattuck Labs | $1.15 | $12.00 | 943.48% | Hold |
| IPSC | Century Therapeutics | $1.17 | $5.00 | 327.35% | Buy |
| MLEC | Moolec Science SA | $0.82 | $3.00 | 265.85% | Buy |
| GPCR | Structure Therapeutics | $31.48 | $99.00 | 214.49% | Buy |
| CVKD | Cadrenal Therapeutics | $11.45 | $32.00 | 179.48% | Buy |
| NUVB | Nuvation Bio | $2.81 | $7.00 | 149.11% | Buy |
| MLYS | Mineralys Therapeutics | $12.35 | $30.00 | 142.91% | Buy |
| LYEL | Lyell Immunopharma | $0.65 | $1.00 | 53.85% | Hold |
| RZLT | Rezolute | $4.44 | $6.67 | 50.23% | Buy |
| CNTA | Centessa Pharmaceuticals | $17.60 | $23.25 | 32.10% | Buy |
| JANX | Janux Therapeutics | $59.61 | $70.25 | 17.85% | Buy |